LVMH-Owned Paris Match Will Buy French Photo Agency Abaca
Paris Match is set to acquire 80% of the agency, the magazine said in a statement seen by Bloomberg. The price of the transaction isn't known. Abaca had revenues of €3.7 million in 2023 ($4.4 million) filings show.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
14 minutes ago
- Newsweek
Full List of NATO Navies Supplying World's Largest Muslim Nation
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Indonesia's defense ministry on Saturday signed an agreement with Turkish officials for the purchase of two frigates. While the deal adds to Jakarta's growing list of procurement contracts with NATO allies, analysts warn that relying on such a diverse mix of foreign manufacturers poses logistical challenges and could strain Indonesia's limited defense budget. Newsweek reached out to the Indonesian defense ministry and Turkish foreign ministry via email for comment. Why It Matters Despite fielding Southeast Asia's largest navy, Indonesia has only a handful of combatant ships—mainly comprising small attack craft suited for operation near the coast and a small fleet of aging submarines. While Indonesia has maintained a policy of neutrality even amid territorial disputes with China, Malaysia and Australia, officials have been working to transition the navy from a green-water force focused on nearshore defense to a blue-water navy able to project power farther from its shores. France French warship builder Naval Group has been contracted to construct two diesel-electric Scorpène-class submarines in Indonesia, which will bring the country's submarine count to six. Indonesian's navy operates two oceanographic research vessels built by France's OCEA Shipbuilding. The Turkish frigate TCG Istanbul sails in the Bosphorus in the centennial ceremony of the Republic of Turkey on October 29, 2023. The Turkish frigate TCG Istanbul sails in the Bosphorus in the centennial ceremony of the Republic of Turkey on October 29, 2023. Wikimedia Commons United Kingdom Two frigates based on the UK's Arrowhead 140 design are being built for Indonesia by state-owned shipbuilder PT PAL under a deal with London-based defense contractor Babcock. British diving and submarine rescue equipment manufacturer Submarine Manufacturing and Products is contracted to provide the Indonesian Navy with its new submarine rescue system. Italy Earlier this month, Indonesia took delivery of the first of two multipurpose offshore patrol vessels it ordered from Italian shipbuilder Fincantieri. The Netherlands Indonesia operates six Dutch-designed, Sigma-class missile-guided corvettes: four Diponegoro-class and two larger, more advanced Martadinata-class ships. Turkey The agreement signed Saturday by Turkish and Indonesian officials will see Turkey's TAIS shipyards build a pair of Istif-class frigates for the Southeast Asian nation. What People Are Saying Collin Koh, senior fellow at the Institute of Defense and Strategic Studies, wrote on X, formerly Twitter: "Dutch corvettes, French + Republic of Korea [South Korea] submarines, British + Turkish frigates, Italian offshore patrol vessels. Mostly involving small quantities of purchase. "A logistical nightmare that doesn't maximize efficient use of limited funds for long-term sustainability of a fleet." SSB, a Turkish government agency tasked with managing defense industry projects, wrote: "This marks Turkey's first export of MİLGEM-class vessels to Indonesia and represents a significant milestone in strategic naval cooperation, bringing pride to our nation. "We hope this collaboration, embodying the shared maritime defense vision of two allied nations, will be beneficial for all parties involved."
Bloomberg
7 hours ago
- Bloomberg
Maybe Joe Rogan Oversold the Texas Dream
Save This is Bloomberg Opinion Today, the adrenalin produced when you round a corner of Bloomberg Opinion's opinions. Sign up here. On the surface, Texas has a lot of things going for it. LVMH CEO Bernard Arnault is planning to open a second factory in the Lone Star State. Hollywood A-listers are hoping producers will set up shop there. And rumor has it that another Tesla Diner might open in Starbase. But peek underneath the hood, and lots of things are going wrong: The first Louis Vuitton factory was a mess. The state's 'faith and family values' message is off-putting for filmmakers. And Elon Musk's fast-casual eatery is off to a rather rocky start, so don't put your money on there being a sequel in the South.
Yahoo
7 hours ago
- Yahoo
DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the 'Company'), today announced the filing, for the semester ended June 30, 2025, of its Half-Year Report with the French market authority, 'Autorité des Marchés Financiers' ('AMF'). The 2025 Half-Year Report can be consulted or downloaded from the Company's website ( in the section Investors/Financial Information, and on the AMF website ( in French only. It is also available free of charge upon request: - by mail : DBV Technologies – 107 avenue de la République 92320 Châtillon, France ; - by email: investors@ About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV is currently focused on investigating the use of its proprietary VIASKIN® patch technology to address food allergies, which are caused by a hypersensitive immune reaction and characterized by a range of symptoms varying in severity from mild to life-threatening anaphylaxis. Millions of people live with food allergies, including young children. Through epicutaneous immunotherapy (EPIT), the VIASKIN® patch is designed to introduce microgram amounts of a biologically active compound to the immune system through intact skin. EPIT is a new class of non-invasive treatment that seeks to modify an individual's underlying allergy by re-educating the immune system to become desensitized to allergen by leveraging the skin's immune tolerizing properties. DBV is committed to transforming the care of food allergic people. The Company's food allergy programs include ongoing clinical trials of VIASKIN Peanut in peanut allergic toddlers (1 through 3 years of age) and children (4 through 7 years of age). DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company's ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345) and the Company's ADSs (each representing five ordinary shares) are traded on the Nasdaq Capital Market (Ticker: DBVT; CUSIP: 23306J309). For more information, please visit and engage with us on X (formerly Twitter) and LinkedIn. Investor Contact Katie MatthewsDBV Media ContactBrett WhelanDBV Attachment PDF VersionSign in to access your portfolio
